Abstract:OBJECTIVE: Canavan disease is an autosomal recessive disorder which is relatively common in Ashkenazi Jews. It is characterized by developmental delay, severe hypotonia and early death, and is caused by a deficiency of aspartoacylase which is encoded by the ASPA gene. In Ashkenazi Jews, one major mutation (E285A) and one minor mutation (Y231X) account for the majority of cases. The objective of this study was to develop a preimplantation genetic diagnosis (PGD) protocol for Canavan disease.METHODS: Two carrier couples requested PGD for Canavan disease. In 1 couple each was a carrier of a different ASPA mutation (Y231X and E285A). In the other couple both were carriers of the minor mutation (Y231X). A single-cell duplex nested polymerase chain reaction (PCR) protocol was first developed on single leukocytes obtained from the known carrier parents. Following verification in single leukocytes, clinical PGD was offered to both couples.RESULTS: We evaluated 115 single leukocytes from known carriers and found an allele drop out rate of 1.7% for the fragment harboring the Y231X mutation and 0% for the fragment harboring the E285A mutation. One cycle of PGD was performed in each family. In the first, 11 embryos were successfully analyzed and 4 were found to be affected. Two unaffected embryos were transferred, but no pregnancy resulted. In the other family, 4 embryos were analyzed, 1 was affected, 2 were heterozygotes and 1 was homozygous normal. Following transfer of 2 unaffected embryos, a singleton pregnancy resulted, currently ongoing at 18 weeks gestational age. Amniocentesis performed at 16 weeks confirmed the diagnosis.CONCLUSION: Reliable PGD for Canavan disease is possible using a single-cell nested PCR approach.

Canavan Disease: Clinical and Laboratory Profile from Southern Part of India

Canavan Disease - A Rare Case Report

Canavan disease: A first case from Jordan

Canavan disease: Clinical features and recent advances in research

Atypical clinical and radiological course of a patient with Canavan disease

Novel mutation in an Egyptian patient with infantile Canavan disease

Two patients with Canavan disease and structural modeling of a novel mutation

New T530C mutation in the aspartoacylase gene caused Canavan disease with no correlation between severity and N-acetylaspartate excretion

Non-genetic therapeutic approaches to Canavan disease

The pathogenesis of, and pharmacological treatment for, Canavan disease

Preimplantation Genetic Diagnosis of Canavan Disease

Clinical and Aspartoacylase Gene Mutation Analysis of Canavan Disease in a Child

A Novel Mutation in Aspartoacylase Gene; Canavan Disease

Canavan Disease: Studies on the Knockout Mouse

Natural history of Canavan disease revealed by proton magnetic resonance spectroscopy (1H-MRS) and diffusion-weighted MRI

Clinically Distinct Phenotypes of Canavan Disease Correlate with Residual Aspartoacylase Enzyme Activity

Severe retinal degeneration in a patient with Canavan disease

[Genetic analysis and prenatal diagnosis for a Chinese pedigree affected with Canavan disease]

A Diagnostic Blind Spot: Deep intronic SVA_E Insertion identified as the most Common Pathogenic Variant Associated with Canavan Disease

A novel Aspartoacylase (ASPA) Gene Mutation in Canavan Disease

Long-term follow-up after gene therapy for canavan disease